| [1] |
Yang YC, Li X, Chen W. Differential expression of immuneassociated genes in two subcloned cell lines from a same human bladder cancer[J]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, 2006, 22 (5): 625-7.[杨玉琮,李旭,陈葳.免疫相关基因在同一膀胱癌 亚克隆细胞株中的差异表达[J]. 细胞与分子免疫学杂志, 2006, 22 (5): 625-7.]
|
| [2] |
Lau GT, Huang H, Lin SM, et al. Butein downregulates phorbol 12 -myristate 13-acetate- induced COX-2 transcriptional activity in cancerous and non-cancerous breast cells[J]. Eur J Pharmacol, 20 10, 648(1-3): 24-30.
|
| [3] |
Chua AW, Hay HS, Rajendran P, et al. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells[J]. Biochem Pharmacol, 2010, 80(10): 1553-62.
|
| [4] |
Rajendran P, Ong TH, Chen L, et al. Suppression of signal transducer and activator of transcription 3 activation by butein inhibits growth of human hepatocellular carcinoma in vivo[J]. Clin Cancer Res, 2011, 17(6): 1425-39.
|
| [5] |
Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science, 2002, 298(5600): 1911-2.
|
| [6] |
Yang EB, Zhang K, Cheng LY, et al. Butein, a specific protein tyrosine kinase inhibitor[J]. Biochem Biophys Res Commun, 19 98, 245(2): 435-8.
|
| [7] |
Yang LH, Ho YJ, Lin JF, et al. Butein inhibits the proliferation of breast cancer cells through generation of reactive oxygen species and modulation of ERK and p38 activities[J]. Mol Med Rep, 20 12, 6(5): 1126-32.
|
| [8] |
Nakano H, Shindo M, Sakon S, et al. Differential regulation of lkappaB kinase alpha and beta by two upstream kinases, NFkappaB- inducing kinase and mitogen-activated protein kinase/ ERK kinase kinase-1[J]. Proc Natl Acad Sci U S A, 1998, 95(7): 35 37-42.
|
| [9] |
Mang YX, Li M. Progress in NF-κB Targeting Drugs for the Prevention and Treatment of Tumor[J]. Zhong Liu Fang Zhi Yan Jiu, 2006, 33(6): 465-7. [马艳霞, 李敏. NF-κB与肿瘤防治药物 研究进展[J]. 肿瘤防治研究, 2006, 33(6): 465-7.]
|
| [10] |
Pandey MK, Sandur SK, Sung B, et al. Butein, atetrahydroxychalcone, inhibits nuclear factor (NF)-kappa B and NF-kappaB-regulated gene expression through direct inhibition of lkappaBalpha kinase beta on cysteine-179 residue[J]. J Biol Chem, 2007, 282(24): 17 340-50.
|
| [11] |
Dahlman JM, Wang J, Bakkar N, et al. The RelA/p65 subunit of NF-kappaB specifically regulates cyclin D1 protein stability: implications for cell cycle withdrawal and skeletal myogenesis[J]. J Cell Biochem, 2009, 106(1): 42-51.
|
| [12] |
Wang S, Liu Z, Wang L, et al. NF-kappaB signaling pathway, inflammation and colorectal cancer[J]. Cell Mol Immunol, 2009, 6( 5): 327-34.
|
下载:
